MRI directed prostate biopsy will change the cancer risk profiles of diagnosed patients, towards those requiring radical treatments. Increased costs can be balanced by improvements in the efficiency of the patient pathway.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Effective communication of imaging findings and improved urological understanding of imaging limitations will improve the quality of care for prostate cancer patients.
European urology. 2015 Aug 08 [Epub ahead of print]
Anwar R Padhani, Giuseppe Petralia, Francesco Sanguedolce
Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Middlesex, UK. Division of Radiology, IEO - European Institute of Oncology, Milan, Italy. , Northampton General Hospital, NHS Trust, Northampton, UK; King's College Hospital, NHS Foundation Trust, London, UK.